Symbolbild · KI-generiert
Ocumetics Technology Corp.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Ocumetics Technology Corp. (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) is a Canadian research and product development company that is dedicated to developing advanced vision correction solutions that enhance the quality of life for patients. Through innovative research and development, Ocumetics aims to transform the field of ophthalmology with state-of-the-art intraocular lenses and other vision-enhancing technologies.
Company description as published by the issuer via TMX Money.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Ocumetics Technology Corp. | OTC | TSXV | 43 Mio. USD |
| Covalon Technologies Ltd. | COV | TSXV | 44 Mio. USD |
| BioMark Diagnostics Inc. | BUX | CSE | 43 Mio. USD |
| Decibel Cannabis Company Inc. | DB | TSXV | 41 Mio. USD |
| Realbotix Corp. | XBOT | TSXV | 46 Mio. USD |
| Eastwood Bio-Medical Canada Inc. | EBM | TSXV | 48 Mio. USD |
| Arch Biopartners Inc. | ARCH | TSXV | 39 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.